Neurofilament Light Chain and Cognitive Dysfunction in Patients Undergoing Hemodialysis: A Cross-Sectional Exploratory Study.
- Published on 07/29/2026
- Reading time: 1 min.
Kato, Kazuhiko; Nakashima, Akio; Shinagawa, Shunichiro; Kobayashi, Arisa; Ohkido, Ichiro; Urashima, Mitsuyoshi; Yokoo, Takashi
Abstract
* Blood biomarkers related to amyloid [beta] and neurofilament light chain are used to predict cognitive decline in the general population.
* Evidence for their usefulness is lacking in patients receiving hemodialysis despite their high risk of cognitive impairment.
* Neurofilament light chain levels were negatively associated with cognitive function, whereas the amyloid [beta] ratio was not.
Background: Cognitive dysfunction is frequently observed...
To continue reading this article in Full-Text...
* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Nephrology
Receive our newsletter to stay up to date with the latest news in Nephrology
More articles
From peer-reviewed journals
in Nephrology




